Stock Events

Twist Bioscience 

$53.44
125
+$0.96+1.83% Friday 20:00

统计数据

当日最高
54.24
当日最低
51.58
52周最高
55.26
52周最低
14.42
成交量
680,916
平均成交量
1,058,764
市值
3.11B
市盈率
-15.95
股息收益率
-
股息
-

收益

2May已确认
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.25
-1.08
-0.91
-0.74
预期每股收益
-0.81
实际每股收益
-0.79

人们还关注

此列表基于关注TWST的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

53$平均价格目标
最高估值为 $65。
来自过去6个月内的 7 个评级。这不是投资建议。
买入
100%
持有
0%
卖出
0%

关于

Health Technology
Biotechnology
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Show more...
首席执行官
Emily Leproust
员工
919
国家
US
ISIN
US90184D1000
WKN
000A2N7L2

上市公司